Latest Lead News

Bravura Solutions has raised its FY26 revenue and cash EBITDA guidance, citing a strong British pound and increased project activity in EMEA as key growth drivers.

Boss Energy has appointed Matthew Dusci as Managing Director and CEO, marking a leadership transition aimed at driving operational focus and production growth at its Honeymoon uranium project.

Broken Hill Mines has locked in a US$25 million senior secured financing facility alongside a major silver-lead concentrate offtake agreement with Hartree Metals, underpinning growth at its Rasp and Pinnacles mines.

Equinox Resources' judicial review over the Hamersley Iron Ore Project has been adjourned to 17 October 2025, as the Supreme Court seeks clarity on mapping and boundary data used by the Committee. The outcome remains uncertain as affidavit evidence is awaited.

Theta Gold Mines Limited has released an optimised feasibility study for its TGME Gold Mine Project, revealing a substantial increase in project value with a 14.5-year life of mine and US$1.2 billion in free cash flow.

Australian Pacific Coal Limited has delayed its full year accounts due to missing financial data from its Dartbrook mine subsidiary, leading to a trading suspension from October 1.

Tamboran Resources is set to acquire Falcon Oil & Gas Ltd., consolidating a dominant position in the Beetaloo Basin with nearly 3 million net prospective acres. The deal, valued at US$172 million, positions Tamboran as a leading Australian E&P player ahead of key development phases.

Tamboran Resources is set to acquire Falcon Oil & Gas, creating a dominant player with approximately 2.9 million net prospective acres in Australia's Beetaloo Basin. The deal, valued at over US$500 million pro forma, aims to strengthen Tamboran's development footprint and shareholder base.

Altech Batteries has partnered with AMPower to immediately market and distribute sodium nickel chloride batteries across Europe, Australia, and the USA, fast-tracking revenue ahead of its large-scale CERENERGY project in Germany.

Invex Therapeutics reveals the collapse of confidential acquisition negotiations following shareholder unrest and potential board changes, clarifying recent unusual trading activity.

Invex Therapeutics has discontinued exclusive negotiations to acquire a rare neurological disease company due to board instability triggered by a shareholder requisition notice. Despite this setback, the company remains committed to diversifying its neurological treatment portfolio.

VEEM Ltd has secured $14 million through a placement to fuel its expansion in defence manufacturing, including a landmark US$33 million licence agreement with Northrop Grumman. The company is poised to accelerate revenue in the second half of FY26 as it deepens ties with major US defence contractors.